While not approved as a smoking-cessation drug, multiple observational studies have reported that patients taking semaglutide experience fewer nicotine urges and increased quit-smoking success rates compared to historical controls
Some studies suggest, for example, that adding curcumin or resveratrol can be a particularly good option
However, outside of clinical trials, weight loss data with liraglutide or semaglutide has been limited to a short follow-up period of six months
Pediatric patients 12 years treated with Wegovy injection had greater incidences of cholelithiasis, cholecystitis, hypotension, rash, and urticaria compared to adults treated with Wegovy
The error bars show the standard deviation of the three replicate experiments
Disclaimer Information provided here are only of supplementary nature